发明名称 HIV-INHIBITING BENZENEACETAMIDE DERIVATIVES
摘要 <p>A compound for use as a medicine having the formula <IMAGE> (I) a pharmaceutically acceptable acid addition salt form or a stereochemically isomeric form thereof, wherein R1 and R2 each independently are hydrogen, C1-6alkyl or C3-6cycloalkyl; or R1 and R2 taken together with the nitrogen atom bearing said R1 and R2 may form a pyrrolidinyl, piperidinyl, morpholinyl, piperazinyl or 4-C1-4alkylpiperazinyl group; X is O or S; R3 is hydrogen or C1-6alkyl; R4, R5 and R6 each independently are hydrogen, halo, C1-6alkyl, C1-6alkyloxy, nitro, trifluoromethyl, cyano, aminomethyl, carboxyl, C1-4alkyloxycarbonyl, C1-4alkyl-carbonyl, aminocarbonyl or hydroxy; R7 is hydrogen or halo; and R8, R9 and R10 each independently are hydrogen, halo, C1-6alkyl, C1-6alkyloxy, nitro, hydroxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, (trifluoromethyl)carbonyl, aminocarbonyl, (cyclopropyl)carbonyl or a radical C1-6alkyl-(C=Y)-wherein =Y represents =O, =N-OH, =N-OCH3, =N-NH2 or =N-N(CH3)2; provided that (1) R1 is other than n-propyl when R2, R3, R4, R5, R6, R7, R9 and R10 represent hydrogen, R8 represents 4-ethoxy and X represents oxygen, and (2) X is other than sulfur, when R1, R2, R3, R6, R7, R8, R9 and R10 represent hydrogen and R4 and R5 represent 3,4-dimethoxy. Novel compounds, pharmaceutical compositions containing said compounds of formula (I), and processes for preparing said compositions.</p>
申请公布号 GR3021829(T3) 申请公布日期 1997.02.28
申请号 GR19960403220T 申请日期 1996.11.28
申请人 JANSSEN PHARMACEUTICA N.V. 发明人 VAN DAELE, GEORGES, HENRI, PAUL;VERDONCK, MARC, GUSTAAF, CELINE;BOSMANS, JEAN-PAUL, RENE, MARIE, ANDRE;JANSSEN, PAUL, ADRIAAN, JAN
分类号 A61K31/155;A61K;A61K31/165;A61K31/235;A61K31/275;A61P31/12;A61P31/18;C07C;C07C45/00;C07C49/813;C07C205/45;C07C205/57;C07C237/06;C07C237/20;C07C237/30;C07C237/42;C07C251/48;C07C251/72;C07C251/86;C07C255/33;C07C255/35;C07C255/41;C07C255/42;C07C255/43;C07C255/57;C07C327/40;C07C327/44;C07D;C07D295/10;C07D295/182;C07D295/194;(IPC1-7):C07C237/20 主分类号 A61K31/155
代理机构 代理人
主权项
地址